Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England.
Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L, Wilcox M, Hope W, Leonard C, Howard P, Jenkins D, Ashworth A, Bentley A, Sculpher M.
Woods B, et al. Among authors: schmitt l.
Appl Health Econ Health Policy. 2024 Nov 30. doi: 10.1007/s40258-024-00924-x. Online ahead of print.
Appl Health Econ Health Policy. 2024.
PMID: 39616299